190 related articles for article (PubMed ID: 35903684)
1. Disturbances of Vaginal Microbiome Composition in Human Papillomavirus Infection and Cervical Carcinogenesis: A Qualitative Systematic Review.
Wu M; Li H; Yu H; Yan Y; Wang C; Teng F; Fan A; Xue F
Front Oncol; 2022; 12():941741. PubMed ID: 35903684
[TBL] [Abstract][Full Text] [Related]
2. Cervical Squamous Intraepithelial Lesions Are Associated with Differences in the Vaginal Microbiota of Mexican Women.
Nieves-Ramírez ME; Partida-Rodríguez O; Moran P; Serrano-Vázquez A; Pérez-Juárez H; Pérez-Rodríguez ME; Arrieta MC; Ximénez-García C; Finlay BB
Microbiol Spectr; 2021 Oct; 9(2):e0014321. PubMed ID: 34643408
[TBL] [Abstract][Full Text] [Related]
3. The Vaginal Microbiota, Human Papillomavirus Infection, and Cervical Carcinogenesis: A Systematic Review in the Latina Population.
Mancilla V; Jimenez NR; Bishop NS; Flores M; Herbst-Kralovetz MM
J Epidemiol Glob Health; 2024 Feb; ():. PubMed ID: 38407720
[TBL] [Abstract][Full Text] [Related]
4. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis.
Norenhag J; Du J; Olovsson M; Verstraelen H; Engstrand L; Brusselaers N
BJOG; 2020 Jan; 127(2):171-180. PubMed ID: 31237400
[TBL] [Abstract][Full Text] [Related]
5. Vaginal Microbiome Dysbiosis is Associated with the Different Cervical Disease Status.
Ma Y; Li Y; Liu Y; Cao L; Han X; Gao S; Zhang C
J Microbiol; 2023 Apr; 61(4):423-432. PubMed ID: 37010797
[TBL] [Abstract][Full Text] [Related]
6. The vaginal microbiota, high-risk human papillomavirus infection, and cervical cytology: results from a population-based study.
McKee KS; Carter KA; Bassis C; Young VB; Reed B; Harper DM; Ruffin MT; Bell JD
Gynecol Pelvic Med; 2020 Sep; 3():. PubMed ID: 35252846
[TBL] [Abstract][Full Text] [Related]
7. Microbiome markers in HPV-positive and HPV-negative women of reproductive age with ASCUS and SIL determined by V4 region of 16S rRNA gene sequencing.
Peremykina A; Cheranev V; Krivoy A; Andreev AO; Repinskaia Z; Asaturova AV; Korostin D; Rebrikov D; Bayramova GR
Front Microbiol; 2024; 15():1334502. PubMed ID: 38550866
[TBL] [Abstract][Full Text] [Related]
8. Imbalance of Vaginal Microbiota and Immunity: Two Main Accomplices of Cervical Cancer in Chinese Women.
Li X; Wu J; Wu Y; Duan Z; Luo M; Li L; Li S; Jia Y
Int J Womens Health; 2023; 15():987-1002. PubMed ID: 37424699
[TBL] [Abstract][Full Text] [Related]
9. Depiction of Vaginal Microbiota in Women With High-Risk Human Papillomavirus Infection.
Wei ZT; Chen HL; Wang CF; Yang GL; Han SM; Zhang SL
Front Public Health; 2020; 8():587298. PubMed ID: 33490017
[TBL] [Abstract][Full Text] [Related]
10. Altered Vaginal Microbiota Composition Correlates With Human Papillomavirus and Mucosal Immune Responses in Women With Symptomatic Cervical Ectopy.
López-Filloy M; Cortez FJ; Gheit T; Cruz Y Cruz O; Cruz-Talonia F; Chávez-Torres M; Arteaga-Gómez C; Mancilla-Herrera I; Montesinos JJ; Cortés-Morales VA; Aguilar C; Tommasino M; Pinto-Cardoso S; Rocha-Zavaleta L
Front Cell Infect Microbiol; 2022; 12():884272. PubMed ID: 35656032
[TBL] [Abstract][Full Text] [Related]
11. Correlation between the diversity of vaginal microbiota and the risk of high-risk human papillomavirus infection.
Chao XP; Sun TT; Wang S; Fan QB; Shi HH; Zhu L; Lang JH
Int J Gynecol Cancer; 2019 Jan; 29(1):28-34. PubMed ID: 30640680
[TBL] [Abstract][Full Text] [Related]
12. Changes in vaginal microbiome after focused ultrasound treatment of high-risk human papillomavirus infection-related low-grade cervical lesions.
Wang W; Liu Y; Yang Y; Ren J; Zhou H
BMC Infect Dis; 2023 Jan; 23(1):3. PubMed ID: 36604622
[TBL] [Abstract][Full Text] [Related]
13. Vaginal microbiota and HPV clearance: A longitudinal study.
Shi W; Zhu H; Yuan L; Chen X; Huang X; Wang K; Li Z
Front Oncol; 2022; 12():955150. PubMed ID: 36353544
[TBL] [Abstract][Full Text] [Related]
14. Research of cervical microbiota alterations with human papillomavirus infection status and women age in Sanmenxia area of China.
Hu J; Wu Y; Quan L; Yang W; Lang J; Tian G; Meng B
Front Microbiol; 2022; 13():1004664. PubMed ID: 36312946
[TBL] [Abstract][Full Text] [Related]
15. Research of the potential biomarkers in vaginal microbiome for persistent high-risk human papillomavirus infection.
Chao X; Sun T; Wang S; Tan X; Fan Q; Shi H; Zhu L; Lang J
Ann Transl Med; 2020 Feb; 8(4):100. PubMed ID: 32175393
[TBL] [Abstract][Full Text] [Related]
16. Vaginal microbiota and human papillomavirus: a systematic review.
Mortaki D; Gkegkes ID; Psomiadou V; Blontzos N; Prodromidou A; Lefkopoulos F; Nicolaidou E
J Turk Ger Gynecol Assoc; 2020 Sep; 21(3):193-200. PubMed ID: 31564082
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: a cross-sectional study.
Gao W; Weng J; Gao Y; Chen X
BMC Infect Dis; 2013 Jun; 13():271. PubMed ID: 23758857
[TBL] [Abstract][Full Text] [Related]
18. [The cervical microbiota characteristics in patients with human papillomavirus infection].
Chen MX; Zhou ZY; Qing W; Li H; Zhou HW
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Jul; 55(7):867-874. PubMed ID: 34304424
[No Abstract] [Full Text] [Related]
19. Changes of vaginal microbiota during cervical carcinogenesis in women with human papillomavirus infection.
So KA; Yang EJ; Kim NR; Hong SR; Lee JH; Hwang CS; Shim SH; Lee SJ; Kim TJ
PLoS One; 2020; 15(9):e0238705. PubMed ID: 32941440
[TBL] [Abstract][Full Text] [Related]
20. Association of high-risk human papillomavirus infection duration and cervical lesions with vaginal microbiota composition.
Liu J; Luo M; Zhang Y; Cao G; Wang S
Ann Transl Med; 2020 Sep; 8(18):1161. PubMed ID: 33241010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]